Gmo Small Cap Fund Market Value

GCAVX Fund  USD 22.86  0.18  0.78%   
Gmo Us' market value is the price at which a share of Gmo Us trades on a public exchange. It measures the collective expectations of Gmo Small Cap investors about its performance. Gmo Us is trading at 22.86 as of the 3rd of December 2024; that is 0.78 percent decrease since the beginning of the trading day. The fund's open price was 23.04.
With this module, you can estimate the performance of a buy and hold strategy of Gmo Small Cap and determine expected loss or profit from investing in Gmo Us over a given investment horizon. Check out Gmo Us Correlation, Gmo Us Volatility and Gmo Us Alpha and Beta module to complement your research on Gmo Us.
Symbol

Please note, there is a significant difference between Gmo Us' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gmo Us is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gmo Us' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Gmo Us 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Gmo Us' mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Gmo Us.
0.00
11/03/2024
No Change 0.00  0.0 
In 31 days
12/03/2024
0.00
If you would invest  0.00  in Gmo Us on November 3, 2024 and sell it all today you would earn a total of 0.00 from holding Gmo Small Cap or generate 0.0% return on investment in Gmo Us over 30 days. Gmo Us is related to or competes with Adams Diversified, Davenport Small, Blackrock, and Lord Abbett. The adviser seeks to achieve the funds investment objective by investing primarily in equities of U.S More

Gmo Us Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Gmo Us' mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Gmo Small Cap upside and downside potential and time the market with a certain degree of confidence.

Gmo Us Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Gmo Us' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Gmo Us' standard deviation. In reality, there are many statistical measures that can use Gmo Us historical prices to predict the future Gmo Us' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Gmo Us' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
21.5222.8624.20
Details
Intrinsic
Valuation
LowRealHigh
21.2122.5523.89
Details
Naive
Forecast
LowNextHigh
21.7023.0324.37
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
22.1922.6323.07
Details

Gmo Small Cap Backtested Returns

At this stage we consider Gmo Mutual Fund to be very steady. Gmo Small Cap holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Gmo Small Cap, which you can use to evaluate the volatility of the entity. Please check out Gmo Us' Risk Adjusted Performance of 0.0784, downside deviation of 1.03, and Market Risk Adjusted Performance of 0.0914 to validate if the risk estimate we provide is consistent with the expected return of 0.17%. The fund retains a Market Volatility (i.e., Beta) of 1.5, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Gmo Us will likely underperform.

Auto-correlation

    
  0.55  

Modest predictability

Gmo Small Cap has modest predictability. Overlapping area represents the amount of predictability between Gmo Us time series from 3rd of November 2024 to 18th of November 2024 and 18th of November 2024 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Gmo Small Cap price movement. The serial correlation of 0.55 indicates that about 55.0% of current Gmo Us price fluctuation can be explain by its past prices.
Correlation Coefficient0.55
Spearman Rank Test-0.11
Residual Average0.0
Price Variance0.2

Gmo Small Cap lagged returns against current returns

Autocorrelation, which is Gmo Us mutual fund's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Gmo Us' mutual fund expected returns. We can calculate the autocorrelation of Gmo Us returns to help us make a trade decision. For example, suppose you find that Gmo Us has exhibited high autocorrelation historically, and you observe that the mutual fund is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Gmo Us regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Gmo Us mutual fund is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Gmo Us mutual fund is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Gmo Us mutual fund over time.
   Current vs Lagged Prices   
       Timeline  

Gmo Us Lagged Returns

When evaluating Gmo Us' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Gmo Us mutual fund have on its future price. Gmo Us autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Gmo Us autocorrelation shows the relationship between Gmo Us mutual fund current value and its past values and can show if there is a momentum factor associated with investing in Gmo Small Cap.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Gmo Mutual Fund

Gmo Us financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Us security.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Bonds Directory
Find actively traded corporate debentures issued by US companies